Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine opioid-free anesthesia for gynecologic laparoscopic surgery
ChiCTR2400085340Phase 4Completed
- Sponsor
- Qilu Hospital of Shandong University Dezhou Hospital
- Start
- Jun 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine, sufentanil and remifentanil in postoperative nausea and vomiting (PONV) and postoperative pain (2 arms), sponsored by Qilu Hospital of Shandong University Dezhou Hospital. Primary endpoint: Incidence of postoperative nausea and vomiting. Started Jun 2024; status: completed.
02
Drugs
esketaminesufentanilremifentanil
03
Conditions
postoperative nausea and vomiting (PONV)postoperative pain
Beyond the preview
Go deeper on ChiCTR2400085340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085340.